CO252 Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.352
https://www.valueinhealthjournal.com/article/S1098-3015(25)02909-2/fulltext
Title :
CO252 Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02909-2&doi=10.1016/j.jval.2025.09.352
First page :
Section Title :
Open access? :
No
Section Order :
12683